Frequently Asked Questions
What is anthrax?
Anthrax is an acute infectious disease caused by the spore-forming bacterium Bacillus
anthracis. Anthrax most commonly occurs in wild and domestic lower vertebrates
(cattle, sheep, goats, camels, antelopes, and other herbivores), but it can also occur in
humans when they are exposed to infected animals or tissue from infected animals.

Why has anthrax become a
current issue?
Because anthrax is considered to be a potential agent for use in
biological warfare, the Department of Defense (DoD) has begun mandatory vaccination of all
active duty military personnel who might be involved in conflict.
How
common is anthrax and who can get it?
Anthrax is most common in agricultural regions where it occurs in animals. These include
South and Central America, Southern and Eastern Europe, Asia, Africa, the Caribbean, and
the Middle East. When anthrax affects humans, it is usually due to an occupational
exposure to infected animals or their products. Workers who are exposed to dead animals
and animal products from other countries where anthrax is more common may become infected
with B. anthracis (industrial anthrax). Anthrax in wild livestock has occurred in
the United States.

How is
anthrax transmitted?
Anthrax infection can occur in three forms: cutaneous (skin), inhalation, and
gastrointestinal. B. anthracis spores can live in the soil for many years, and
humans can become infected with anthrax by handling products from infected animals or by
inhaling anthrax spores from contaminated animal products. Anthrax can also be spread by
eating undercooked meat from infected animals. It is rare to find infected animals in the
United States.

What
are the symptoms of anthrax?
Symptoms of disease vary depending on how the disease was contracted, but symptoms usually
occur within 7 days.
Cutaneous: Most (about 95%) anthrax infections occur when
the bacterium enters a cut or abrasion on the skin, such as when handling contaminated
wool, hides, leather or hair products (especially goat hair) of infected animals. Skin
infection begins as a raised itchy bump that resembles an insect bite but within 1-2 days
develops into a vesicle and then a painless ulcer, usually 1-3 cm in diameter, with a
characteristic black necrotic (dying) area in the center. Lymph glands in the adjacent
area may swell. About 20% of untreated cases of cutaneous anthrax will result in death.
Deaths are rare with appropriate antimicrobial therapy.
Inhalation: Initial symptoms may resemble a common cold.
After several days, the symptoms may progress to severe breathing problems and shock.
Inhalation anthrax is usually fatal.
Intestinal: The intestinal disease form of anthrax may
follow the consumption of contaminated meat and is characterized by an acute inflammation
of the intestinal tract. Initial signs of nausea, loss of appetite, vomiting, fever are
followed by abdominal pain, vomiting of blood, and severe diarrhea. Intestinal anthrax
results in death in 25% to 60% of cases.

Where
is anthrax usually found?
Anthrax can be found globally. It is more common in developing countries or countries
without veterinary public health programs. Certain regions of the world (South and Central
America, Southern and Eastern Europe, Asia, Africa, the Caribbean, and the Middle East)
report more anthrax in animals than others.
Can
anthrax be spread from person-to-person?
Direct person-to-person spread of anthrax is extremely unlikely to occur. Communicability
is not a concern in managing or visiting with patients with inhalational anthrax.

Is there a way to
prevent infection?
In countries where anthrax is common and vaccination levels of animal
herds are low, humans should avoid contact with livestock and animal products and avoid
eating meat that has not been properly slaughtered and cooked. Also, an anthrax vaccine
has been licensed for use in humans. The vaccine is reported to be 93% effective in
protecting against anthrax.
What is the anthrax
vaccine?
The anthrax vaccine is manufactured and distributed by BioPort,
Corporation, Lansing, Michigan. The vaccine is a cell-free filtrate vaccine, which means
it contains no dead or live bacteria in the preparation. The final product contains no
more than 2.4 mg of aluminum hydroxide as adjuvant. Anthrax vaccines intended for animals
should not be used in humans.

Who should get vaccinated
against anthrax?
The Advisory Committee on Immunization Practices has recommend anthrax
vaccination for the following groups:
- Persons who work directly with the organism in the laboratory
- Persons who work with imported animal hides or furs in areas where standards are
insufficient to prevent exposure to anthrax spores.
- Persons who handle potentially infected animal products in high-incidence areas.
(Incidence is low in the United States, but veterinarians who travel to work in other
countries where incidence is higher should consider being vaccinated.)
- Military personnel deployed to areas with high risk for exposure to the organism (as
when it is used as a biological warfare weapon).
The anthrax Vaccine Immunization Program in the U.S. Army Surgeon General's Office can
be reached at 1-877-GETVACC (1-877-438-8222). http://www.anthrax.osd.mil
Pregnant women should be vaccinated only if absolutely necessary.
What is the protocol for anthrax
vaccination?
The immunization consists of three subcutaneous injections given 2 weeks apart followed
by three additional subcutaneous injections given at 6, 12, and 18 months. Annual booster
injections of the vaccine are recommended thereafter.
Are there adverse reactions to the
anthrax vaccine?
Mild local reactions occur in 30% of recipients and consist of slight tenderness and
redness at the injection site. Severe local reactions are infrequent and consist of
extensive swelling of the forearm in addition to the local reaction. Systemic reactions
occur in fewer than 0.2% of recipients.

How is
anthrax diagnosed?
Anthrax is diagnosed by isolating B. anthracis from the blood, skin lesions, or
respiratory secretions or by measuring specific antibodies in the blood of persons with
suspected cases.
Is there a
treatment for anthrax?
Doctors can prescribe effective antibiotics. To be effective, treatment should be
initiated early. If left untreated, the disease can be fatal.

Where can I get more information about the recent Department of
Defense decision to require men and women in
the Armed Services to be vaccinated against anthrax?
The Department of Defense recommends that servicemen and women contact their chain of
command on questions about the vaccine and its distribution. The anthrax Vaccine
Immunization Program in the U.S. Army Surgeon General's Office can be reached at
1-877-GETVACC (1-877-438-8222). http://www.anthrax.osd.mil |